Sachem Head Capital Management 13F holdings, Q1 2015
Holdings as of March 31, 2015 · filings on SEC EDGAR · latest filing →
Sachem Head Capital Management disclosed 8 US equity positions worth $1.5bn in its Q1 2015 13F filing. The largest position was CDK at 39.2% of the reported book, followed by ACTAVIS PLC and ZTS. Against the Q4 2014 filing, it opened 3 new positions, added to 0 and reduced 0 among the top 8 holdings.
What did Sachem Head Capital Management own in Q1 2015? Top 8 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2014 |
|---|---|---|---|---|---|---|---|
| 1 | CDK CDK GLOBAL INC | 39.2% | $591.4m | 12,647,333 | 0% | held | |
| 2 | ACTAVIS PLC | 15.8% | $238.1m | 800,000 | 0% | held | |
| 3 | ZTS ZOETIS INC | Healthcare | 13.5% | $203.4m | 4,395,000 | 0% | held |
| 4 | APD AIR PRODS & CHEMS INC | Basic Materials | 8.7% | $131.6m | 870,000 | 0% | held |
| 5 | SALIX PHARMACEUTICALS INC | 8.3% | $125.4m | 725,000 | – | new | |
| 6 | MYLAN N V | 7.6% | $115.4m | 1,945,000 | – | new | |
| 7 | TWENTY FIRST CENTY FOX INC | 4.4% | $66.7m | 1,971,762 | 0% | held | |
| 8 | BIO BIO RAD LABS INC | Healthcare | 2.5% | $37.9m | 280,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.